Autoimmune Anemia in Malaria
- PMID: 31864893
- PMCID: PMC7101069
- DOI: 10.1016/j.pt.2019.12.002
Autoimmune Anemia in Malaria
Abstract
Severe anemia is a major cause of death by malaria. The loss of uninfected erythrocytes is an important contributor to malarial anemia; however, the mechanisms underlying this pathology are not well understood. Malaria-induced anemia is related to autoimmune antibodies against the membrane lipid phosphatidylserine (PS). In mice, these antibodies induce the clearance of uninfected erythrocytes after binding to PS exposed in their membrane. In human malaria patients there is a strong correlation between anemia and anti-PS antibodies. During malaria, anti-PS antibodies are produced by atypical B cells, whose levels correlate with the development of anemia in patients. Autoimmune responses, which are documented frequently in different infections, contribute to the pathogenesis of malaria by inducing the clearance of uninfected erythrocytes.
Keywords: Plasmodium falciparum; Plasmodium vivax; antiphosphatidylserine antibodies; atypical B cells; autoantibodies; autoimmunity.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures
References
-
- WHO. World malaria report 2018. 2018.
-
- Jakeman GN, Saul A, Hogarth WL, Collins WE. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology. 1999;119 ( Pt 2):127–33. - PubMed
-
- Collins WE, Jeffery GM, Roberts JM. A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am J Trop Med Hyg. 2003;68(4):410–2. Epub 2003/07/24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
